Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bridges Investment Management Inc.

Bridges Investment Management Inc. reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 172,146 shares of the medical equipment provider's stock after selling 1,517 shares during the period. Intuitive Surgical makes up 1.2% of Bridges Investment Management Inc.'s portfolio, making the stock its 23rd largest holding. Bridges Investment Management Inc.'s holdings in Intuitive Surgical were worth $85,259,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Atala Financial Inc purchased a new position in shares of Intuitive Surgical during the 4th quarter worth about $25,000. Chilton Capital Management LLC boosted its position in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after buying an additional 43 shares during the period. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. Global Financial Private Client LLC boosted its position in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares during the period. Finally, Elite Financial Inc. purchased a new stake in Intuitive Surgical in the 1st quarter valued at about $26,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Finally, Barclays reduced their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $592.59.

Intuitive Surgical Trading Down 2.7%

Shares of ISRG stock traded down $13.99 during trading hours on Friday, hitting $512.06. The company's stock had a trading volume of 2,951,229 shares, compared to its average volume of 1,679,961. The company has a 50 day moving average of $537.85 and a 200 day moving average of $536.69. The stock has a market cap of $183.53 billion, a PE ratio of 75.08, a price-to-earnings-growth ratio of 5.58 and a beta of 1.64. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the firm posted $1.50 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president directly owned 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.